NutriBand (NTRB) FCF Margin (2018 - 2026)
NutriBand (NTRB) posted FCF Margin of 129.93% for Q2 2026, up 28.86% sequentially from 182.63% in Q1 2026, and up 7119.0% YoY from 1.8% in Q2 2025.
NutriBand (NTRB) FCF Margin (2018 - 2026) Analysis & Trends
NutriBand has reported FCF Margin for 9 years, with the latest figure at 129.93% in Q2 2026.
- Quarterly FCF Margin rose 7119.0% year-over-year to 129.93% in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 241.91% (down 2424.0% YoY) and the FY2026 annual result came in at 252.37%, down 3183.0% from the prior year.
- FCF Margin improved to 129.93% in Q2 2026 per NTRB's latest filing, from 182.63% in the prior quarter.
- Over five years, FCF Margin peaked at 84.42% in Q4 2022 and troughed at 506.41% in Q4 2025.
- A 5-year average of 206.77% and a median of 187.77% in 2025 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2022 and 2025: FCF Margin soared 34338 bps in 2022, then slumped 34280 bps in 2025.
- Over 5 years, FCF Margin stood at 84.42% in 2022, then plunged by 195 bps to 248.75% in 2023, then jumped by 34 bps to 163.61% in 2024, then slumped by 210 bps to 506.41% in 2025, then jumped by 74 bps to 129.93% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 129.93%, 182.63%, and 506.41% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 22.62% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -22.35% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 70.82% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 41.07% |
| 10 | NutriBand | 46.38 Mn | 42.37 Mn | 196,801.00 | -129.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -129.93% |
| Jan 31, 2026 | -182.63% |
| Oct 31, 2025 | -506.41% |
| Jul 31, 2025 | -210.99% |
| Apr 30, 2025 | -201.11% |
| Jan 31, 2025 | -192.91% |
| Oct 31, 2024 | -163.61% |
| Jul 31, 2024 | -357.39% |
| Apr 30, 2024 | -205.64% |
| Jan 31, 2024 | -146.27% |
| Oct 31, 2023 | -248.75% |
| Jul 31, 2023 | -151.71% |
| Apr 30, 2023 | -157.78% |
| Jan 31, 2023 | -156.20% |
| Oct 31, 2022 | -84.42% |
| Jul 31, 2022 | -204.47% |
| Apr 30, 2022 | -164.89% |
| Jan 31, 2022 | -256.69% |
| Oct 31, 2021 | -427.80% |
| Jul 31, 2021 | -46.39% |